Impulse magnetic-field therapy for erectile dysfunction: A double-blind, placebo-controlled study


This double-blind, placebo-controlled study assessed the efficacy of 3 weeks of impulse magnetic-field therapy for erectile dysfunction (ED). Twenty volunteers who suffered from ED or orgasmic disturbances were randomly assigned to either active treatment or placebo (n = 10 each). Efficacy was assessed in terms of intensity and duration of erection, general well-being, sexual activity, and warm sensation in the genital area. In the active-treatment group, all efficacy endpoints were significantly improved at study end (P=.01), with 80% reporting increases in intensity and duration of erection, frequency of genital warmth, and general wellbeing. The remaining 20%, who experienced minor improvements, were found to have an influenza-like infection after the study that may have influenced their results. Only 30% of the placebo group noted some improvement in their sexual activity; 70% had no change. No side effects were reported.

This is a preview of subscription content, access via your institution.


  1. 1.

    Korenman SG. New insights into erectile dysfunction: a practical approach.Am J Med. 1998; 105:135–144.

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Virag R, Beck-Archily L. Nosology, epidemiology, clinical quantification of erectile dysfunction.Rev Med Int. 1997;1:10–13.

    Article  Google Scholar 

  3. 3.

    Goldmeier D, Keane FE, Carter P, Hessman A, Harris JRW, Renton A. Prevalence of sexual dysfunction in heterosexual patients attending a central London genitourinary medicine clinic.Int J STD AIDS. 1997;8:303–306.

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Read S, King M, Watson J. Sexual dysfunction in primary care. Prevalence, characteristics and detection by the general practitioner.J Public Health Med. 1997;19:387–391.

    PubMed  CAS  Google Scholar 

  5. 5.

    Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction.Am J Cardiol. 2000;86:41–45.

    Article  Google Scholar 

  6. 6.

    Keene LC, Davies PH. Drug-related erectile dysfunction.Adverse Drug React Toxicol Rev. 1999; 18:5–24.

    PubMed  CAS  Google Scholar 

  7. 7.

    Waldinger MD, Olivier B. Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations.Int Clin Psychopharmacol. 1998;13:27–33.

    Article  Google Scholar 

  8. 8.

    Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?Urology. 2000;56:302–306.

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction.J Urol. 1999;161:5–11.

    PubMed  Article  CAS  Google Scholar 

  10. 10.

    Levy A, Crowley T, Gingell C. Non-surgical management of erectile dysfunction.Clin Endocrinol. 2000;52:263–270.

    Google Scholar 

  11. 11.

    McPhee SJ, Lingappa VR, Ganong WF, Lange JD.Pathophysiology of Disease: An Introduction to Clinical Medicine. 3rd ed. Los Altos, Calif: Lange Medical Books; 2000.

    Google Scholar 

  12. 12.

    Psychorembel. In:Klinisches Wörterbuch. 258th ed. Hilderbrandt H, ed. Berlin: Walter de Gruyter; 1998.

  13. 13.

    Araujo AB, Johannes CB, Feldman HA, Derby CA, McKinlay JB. Relation between psychosocial risk factors and incident erectile dysfunction: prospective results from the Massachusetts Male Aging Study.Am J Epidemiol. 2000;152:533–541.

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Manning M, Spahn M, Jünemann K-P. Gefäßflchirurgie, Implantationschirurgie und Vakuumerektionshilfe.Urologie A. 1998;37:509–515.

    Article  CAS  Google Scholar 

  15. 15.

    Khan MA, Thompson CS, Sullivan ME, Jeremy JY, Mikhailidis DP, Morgan RJ. The role of prostaglandins in the aetiology and treatment of erectile dysfunction.Prostaglandins Leukot Essent Fatty Acids. 1999;60:169–174.

    PubMed  Article  CAS  Google Scholar 

  16. 16.

    Rutherford D, Duffy FJR, Current treatment of impotence: Viagra and other options.Br J Nurs. 1999;8:235–241.

    PubMed  CAS  Google Scholar 

  17. 17.

    Weig W. Die Rolle von Psychiatrie und Psychotherapie in der Sexualmedizin nach der Markteinführung von Viagra®.Nervenarzt. 2000;71:218–221.

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    Jeunemann K, Alken P. Pharmacology of erectile dysfunction: a review.Int J Impot Res. 1989; 1:71–93.

    Google Scholar 

  19. 19.

    Akimov G, Ponizowski V. Effects of alternating field on healing of ulcers of the lower extremities.Vestn Chir. 1977;119:84–85.

    Google Scholar 

  20. 20.

    Basset C, Pilla AA, Mitchell SN, Pawluk RJ. Nonoperative treatment of pseudoarthroses and nonunions by pulsing electromagnetic fields.Orthop Trans J Bone Joint Surg. 1978;2:218.

    Google Scholar 

  21. 21.

    Bergsmann O. Selektive Feldtherapie bei pseudoradikulären Symptomen. In:Manuelle Medizin, XXI. Vienna, Austria; 1983.

  22. 22.

    Cameron H, Park YS. An examination of the effects of pulsed magnetic fields on knee swelling following total knee replacement. Presented at the International Congress on Foot and Hand Surgery; 1981; São Paulo, Brazil.

  23. 23.

    Ehrmann W, von Leitner H, Ludwig W. Therapie mit ELF-Magnetfeldern.Z Phys Med. 1976; 4:161–170.

    Google Scholar 

  24. 24.

    Evertz U, König H. Pulsierende magnetische Felder in ihrer Bedeutung für die Medizin.Hippokrates. 1977;1:16.

    Google Scholar 

  25. 25.

    Shafik A. Effect of magnetic stimulation on the contractile activity of the rectum in dog.Eur Surg Res. 1998;30:268–272.

    PubMed  Article  CAS  Google Scholar 

  26. 26.

    Shafik A, el-Sibai O. Effect of magnetic stimulation on the contractile activity of the rectum in humans.Am Surg. 2000;66:491–494.

    PubMed  CAS  Google Scholar 

  27. 27.

    Shafik A. Magnetic stimulation: a novel method for the treatment of chronic constipation.Minim Invasive Ther Allied Technol. 1998;7:477–481.

    Article  Google Scholar 

  28. 28.

    Shafik A. Penile erection in dogs by magnetic stimulation of the cavernous nerve.Arch Androl. 1999;43:247–252.

    PubMed  Article  CAS  Google Scholar 

  29. 29.

    Shafik A, el-Sibai O, Shafik AA. Magnetic stimulation of the cavernous nerve for the treatment of erectile dysfunction in humans.Int J Impot Res. 2000;12:137–142.

    PubMed  Article  CAS  Google Scholar 

  30. 30.

    Hainovici N, Negoesen J. Beeinflussung der Kallusbildung unter der Behandlung mit niederfrequenten gepulsten Magnetfeldern.Therapiewoche. 1987;30:4619–4631.

    Google Scholar 

  31. 31.

    Pelka RB, de Moliere M.Migräne, Wetterfühligkeit und Spannungskopfschmerz: Essentielle Linderung durch Magnetwechselfelder? Notabene Medici; 1989.

  32. 32.

    Watson J, Downes E. Clinical aspects of the stimulation of bone healing using electrical phaenomena.Med Biol Eng Comput. 1979;17:261.

    Article  Google Scholar 

  33. 33.

    Tan HL. Economic costs of male erectile dysfunction using a decision analytic model.Pharmacoeconomics. 2000;17:77–107.

    PubMed  Article  CAS  Google Scholar 

  34. 34.

    Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States. Prevalence and predictors.JAMA. 1999;281:537–544.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Rainer B. Pelka Ph.D..

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pelka, R.B., Jaenicke, C. & Gruenwald, J. Impulse magnetic-field therapy for erectile dysfunction: A double-blind, placebo-controlled study. Adv Therapy 19, 53 (2002).

Download citation


  • erectile dysfunction
  • magnetic waves
  • alternative therapy
  • impulse magnetic-field therapy